|
|
||||||||
1From the Division of Ophthalmology, Childrens Hospital of Philadelphia and the University of Pennsylvania, Philadelphia, Pennsylvania; the 2Department of Ophthalmology, University of Minnesota, Minneapolis, Minnesota; the 3Department of Ophthalmology and Vision Science Research Program, University Health Network, Toronto, Ontario, Canada; the 4Department of Research, Nemours Childrens Clinic, Wilmington, Delaware; the 5Department of Oncology, Biology, and Genetics, University of Genoa, Genoa, Italy; the 6Department of Genetics and Orthopedics, Hospital for Sick Children, Toronto, Ontario, Canada; and the 7Department of Medicine and Institute of Human Genetics, University of Minnesota, Minneapolis, Minnesota.
| Abstract |
|---|
|
|
|---|
METHODS. A multigeneration English/Canadian family with AD severe myopia was ascertained. Myopes were healthy, with no clinical evidence of syndromic disease, anterior segment abnormalities, or glaucoma. The family contained 22 participating members (12 affected). The average age of diagnosis of myopia was 8.9 years (range, birth to 11 years). The average refractive error for affected adults was -13.925 D (range, -5.50 to -50.00). Microsatellite markers for genotyping were used to assess linkage to several candidate loci, including three previously identified AD high-myopia loci on 18p11.31, 12q22-q23, and 7q36. Syndromic myopia linkage was excluded by using intragenic or flanking markers for Stickler syndrome types 1, 2, and 2B; Marfan syndrome; Ehlers-Danlos syndrome type 4; and juvenile glaucoma. A full genome screening was performed, with 327 microsatellite markers spaced by 5 to 10 cM. Two-point linkage was analyzed using the FASTLINK program run at 90% penetrance and a myopia gene frequency of 0.0133.
RESULTS. Linkage to all candidate loci was excluded. The genome screening yielded a maximum two-point lod score of 3.17 at
= 0 with microsatellite marker D17S1604. Fine mapping and haplotype analysis defined the critical interval of 7.71 cM at 17q21-22.
CONCLUSIONS. A novel putative disease locus for AD high-grade myopia has been identified and provides additional support for genetic heterogeneity for this disorder.
High myopia (refractive spherical dioptric power of -5.00 or higher) is a major cause of legal blindness in many developed countries.6 7 9 13 14 15 It affects 27% to 33% of all myopic eyes, corresponding to a prevalence of 1.7% to 2% in the general population of the United States.1 5 High myopia is especially common in Asia.13 14 16 In Japan, pathologic or high myopia reportedly affects 6% to 18% of myopes and 1% to 2% of the general population.13 Comparative prevalence rates from different countries show considerable variability, but confirm that myopia affects a significant proportion of the population in many countries.2 9 13 14 15 16
Determining the role of genetic factors in the development of nonsyndromic myopia has been hampered by the high prevalence, genetic heterogeneity, and clinical spectrum of this condition. However, substantial efforts have been made in recent years. These efforts include an increased concordance of refractive error and refractive component (axial length, corneal curvature, lens power, anterior chamber depth) in monozygotic twins compared with dizygotic twins.17 18 19 20 Twin studies estimate a notable heritability value, that is the proportion of the total phenotypic variance that is due to genes, of more than 0.5 to 0.87.17 18 19 20 Many studies report a positive correlation between parental myopia and myopia in their children, further suggesting a hereditary factor in myopia susceptibility.21 22 23 24 A segregation analysis of high myopia performed by Naiglin et al.25 suggested an autosomal dominant (AD) mode of inheritance for their cohort study.
Despite the impediments inherent in mapping genes for a complex common disorder such as myopia, some progress has been made. An X-linked recessive form of myopia has been mapped and was designated the first myopia locus, MYP1.26 We have also studied several medium to large multigenerational families with AD high myopia and found significant linkage at 18p11.31 (MYP2) and 12q23.1-24 (MYP3).27 28 Recently, a novel locus for AD high myopia has been reported on 7q36.29
We now report significant linkage of AD high-grade nonsyndromic myopia to a novel autosomal locus on the long arm of chromosome 17 in a single large family, which did not show linkage to the 18p, 12q, or 7q loci. The proband had a severe myopic refractive error of approximately -50.00 D bilaterally, but the spectrum of myopic refractive error in the family was variable.
| Subjects and Methods |
|---|
|
|
|---|
A comprehensive ophthalmic examination and blood collection were performed by two of the authors (TLY, EH), as previously described.27 In most instances, participants declined axial-length measurement of their eyes. Details of the ophthalmic examination are summarized in Table 1 .
|
DNA analysis was performed as previously described, using multiplexed primer pairs and fluorescence detection techniques initially with an infrared sequencer (model DNA 4000; Li-Cor, Lincoln, NE),27 and subsequently using an automated DNA sequencer (Prism 377; Applied Biosystems, Inc., Foster City, CA). Polymorphic microsatellite markers from three commercial sets (Weber 4a and 8a; ResGen, Huntsville, AL, and ABI HD-10; Applied Biosystems) and custom-made markers selected from genetic maps available on electronic databases were used. Three to four primer pairs were multiplexed in the amplification reaction. For fine mapping, additional markers were selected from genetic maps of 17q and publicly available maps.30 31
Linkage analysis was performed as previously accomplished for the 18p and 12q loci.27 28 Standard marker databases used for intermarker recombination frequencies and order were Genome Data Base,32 Gènèthon,33 the Cooperative Human Linkage Center, and the Marshfield Center for Medical Genetics. See the Appendix for information on databases used in the study. Genetic distances between isolated 17q markers were additionally determined by using the CEPH panel of reference families and the analysis program CRIMAP,33 as well as by radiation hybrid analysis of chromosome 17 markers, using the automated services for radiation hybrid mapping of the Stanford Institute for Genome Research.34 Pair-wise linkage analysis was performed with the MLINK and ILINK programs from the FASTLINK 4.0 software package.35 36 37 Individuals with myopia of -5.00 D or worse were defined as affected, and all others were classified as unaffected. The analysis was run at 90% penetrance, using a myopia gene frequency of 0.0133. Analysis was performed with GeneHunter, a nonparametric multipoint method.38 A different multipoint linkage analysis was performed using the program VITESSE.39
| Results |
|---|
|
|
|---|
|
= 0.0 were as follows: D18S63, -6.43; D18S476, -11.01; D18S481, -10.45; D12S78, -3.92; PAH, -8.50; D7S2423, -7.94; D7S550, -13.15; D7S789, -4.42; D12S1620, -0.95; D6S276, -10.14; D1S535, -5.34; D15S648, -5.71; exon 25 of Col 1A1, -1.89; D1S218, -2.98; D1S215, -7.36; and D1S196, -3.90.
A two-point lod score of 1.94, suggestive of linkage, was initially obtained with microsatellite marker D17S1290 after a genome screening (with a lod score range of +0.87 for marker D13S317 and -14.25 for marker D7S3058). Fine mapping of 17q, using additional flanking markers, was undertaken for haplotype analysis. It was noted that two individuals (12 and 20) with moderately high myopic refractive errors shared the same haplotype as their relatives with high myopia. Individual 20 had a refractive error of -4.25+1.25x2 OD, and -4.50+1.00x175 OS at age 17 years when he was initially ascertained. His most recent refraction at 20 years of age was -4.50+1.25x180 OD and -5.50+1.25x175 OS, indicating a pubertal myopic shift. His disease phenotype was then changed from unaffected to affected with this information. The disease phenotype of individual 12 was not changed, because it did not fit the affected criterion (myopia of -5 D or worse). When the analysis was repeated with the additional markers and the new disease phenotype in individual 20, a maximum lod score of 3.17 at
= 0.0 with marker D17S1604 was obtained. (Table 2) . The refractive error information from all other participants (most were older adults) had not changed during this period.
|
Maximum lod scores of 3.14 and 3.13 at
= 0.0 was obtained for markers D17S1604 and D17S1606, respectively. In general, lod scores obtained using estimated marker allele frequencies did not differ by more than ±0.10, on average (range, 0.010.28), from those reported in Table 2 , in which equal allele frequencies were used.
To maximize the linkage information and minimize the effect of unknown marker allele frequencies, we also performed multipoint analysis using the program VITESSE39 and markers D17S1606, D17S957, D17S1604, and D17S1290. A maximum multipoint lod score of 3.3 was obtained over the whole interval defined by these markers, confirming the positive finding of the two-point analysis. Analysis using GeneHunter did not contribute any additional mapping data.
Haplotype analysis revealed recombination events that narrowed the critical region containing the gene to 7.71 cM, between markers D17S787 and D17S1811 (Fig. 2) . A centromeric recombinant event was noted between markers D17S790 and D17S787 in the second generation, in that affected individual 4 did not share the same haplotype for markers proximal to D17S787 as her affected siblings 6 and 8. A second centromeric recombination event occurred between markers D17S787 and D17S1606 in affected individual l6. This limit of the critical region is supported by a centromeric recombination event between the same markers in the unaffected individual 25 who shares the affected centromeric haplotype of the left branch of the pedigree. A telomeric recombination event was observed between markers D17S1290 and D17S1811, in the affected individual 6 and her offspring, individuals 16 and 17, defining the distal limit of the critical region.
|
1 (I) chains. We did not find any anomalies in the type I, III, or V collagen chains (data not shown). | Discussion |
|---|
|
|
|---|
The proband (individual 9) had the highest documented level of myopic refractive error in our clinical experience, which varies between -50 and -60 D. He wore a combination of contact lenses and spectacles for functional vision, and despite these aids he was legally blind (best corrected visual acuity of 20/400 or worse). Both he and his brother (individual 10) had had multiple laser surgeries for retinal holes. His brother had undergone recent cataract surgery for premature cataract, and a -10-D lens was inserted. (Typically, a +20- to 22-D lens is used.) Despite the severe myopia most affected members exhibited, there were two carriers of the putative disease haplotype with more moderate degrees (individuals 12 and 20), reflecting variability in the phenotype and possible modifying factors. The phenotypic variability and somewhat arbitrary assignment of affection status underscores the difficulty in mapping analyses when applying a dichotomous phenotype model to a quantitative trait.
The sclera, the white tough outer covering of the eye, is connective tissue that provides the structural framework for defining the shape and axial length of the eye. The extracellular matrix of the sclera contains collagen fibrils in close association with proteoglycans and glycoproteins.41 42 Alterations in any of these extracellular matrix components are likely to lead to changes in scleral shape, which in turn could affect visual acuity, because the axial length of the eye is a major component in determining ocular refraction. Genes responsible for several syndromic forms of myopia have been identified: collagen 2A1 and 11A1 for Stickler syndromes type 1 and 2 respectively, lysyl-protocollagen hydroxylase for type VI Ehlers-Danlos syndrome, collagen 18A1 for Knobloch syndrome, and fibrillin for Marfan syndrome.43 44 45 46 47 Each of these genes is expressed in the sclera and serves as a model for possible candidate genes for nonsyndromic high myopia.
Many potential candidate genes in the critical region were identified. The UniGene, Human Gene Map, Celera, and UCSC databases revealed 90 expressed sequence tags and 30 sequences for regulatory or structural genes between markers D17S787 and D17S1811.
We initially selected the extracellular matrix proteins COL1A1 and chondroadherin (CHAD) as the most obvious functional candidate genes for high myopia on 17q. Expression of COL1A1 has been noted in skin, tendon, and bone. Mutations in COL1A1 have been described in individuals with type 1 osteogenesis imperfecta, Ehlers-Danlos syndrome type VIIA and VIIB, osteoporosis, and Marfan syndrome, all systemic disorders with scleral thinning and myopia as a clinical component.48 CHAD is a cell-binding, leucine-rich repeat proteoglycan present in the extracellular matrix of cartilage and has been shown to interact with collagen and influence collagen fibril assembly.49 50 Direct sequence screening analysis of the coding regions of both genes did not reveal any disease-causing mutations (data not shown). Other candidate genes are under investigation. A refinement of the candidate region may be necessary before a systematic mutation screening of the genes located in the region can be undertaken.
In summary, we have mapped a new genetic locus for AD high myopia. We continue with our efforts to reduce the 7.71-cM critical region for high myopia through recruitment and analysis of new families before conducting further candidate gene analysis to identify the gene responsible for this myopia phenotype. Mutational characterization of the genes for high myopia will provide additional insight into the molecular mechanisms underlying this most common form of visual impairment and into the regulation of eye growth.
| Appendix 1 |
|---|
|
|
|---|
Columbia University Genome Center, Columbia University, New York, NY (for linkage analysis software). ftp://ftp.ebi.ac.uk/pub/software/linkage_and_mapping/linkage_cpmc_columbia/analyze/.
Cooperative Human Linkage Center, Laboratory for Population Genetics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (for marker and gene loci). http://www.chlc.org/chlcmaps.html/
Gènèthon, French Association against Myopathies, Evry, France (for genetic markers and maps). http://ww.genethon.fr/.
Genome Database, an internation collaboration hosted by The Hospital for Sick Children, Toronto, Ontario Canada (for marker and gene loci). http://gdbwww.gdb.org/.
Human Genome Mapping Project Resources Center, Cambridge, UK (MLINK and ILINK programs of FASTLINK, ver. 4.0) http:www.hgmp.mrc.ac.uk/.
Human Gene Nomenclature Committee, Centre for Human Genetics, University College London, London, UK (for abbreviated gene name assignment). http://www.gene.ucl.ac.uk/cgi-bin/nomenclature/search genes.pl/.
Human Genome Project Working Draft ("Golden Path"), UCSC Genome Bioinformatics, University of California at Santa Cruz, Santa Cruz, CA. http://genome.ucsc.edu/.
Marshfield Laboratories, Marshfield, WI: (for genetic markers and maps). http://www.marshmed.org/genetics/.
National Center for Biotechnology Information, National Institutes of Health, Bethesda, MD (for BLAST searches, EST data, the Human Gene Map, and the UniGene and SAGE Collections). http://www.ncbi.nlm.nih.gov/.
Online Mendelian Inheritance in Man (OMIM), National Center for Biotechnology Information, National Institutes of Health, Bethesda, MD (for accession numbers MYP1 [MIM 310460], MYP2 [MIM 160700], MYP3 [MIM 603221]). http://www.ncbi.nlm.nih.gov/omim/.
Rockefeller University Statistical Genetics, Rockefeller University, New York, NY (for linkage analysis software GeneHunter). ftp://linkage.rockefeller.edu/.
Stanford Institute for Genome Research, Stanford University, Stanford, CA. http://www.shgc.stanford.edu/.
The Whitehead Institute, Massachusetts Institute of Technology, Cambridge, MA (PedManager, pedigree data). http://www.genome.wi.mit.edu/ftp/distribution/software/pedmanager/.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication July 10, 2002; revised October 3 and November 22, 2002; accepted December 11, 2002.
Disclosure: P. Paluru, None; S.M. Ronan, None; E. Heon, None; M. Devoto, None; S.C. Wildenberg, None; G. Scavello, None; A. Holleschau, None; O. Mäkitie, None; W.G. Cole, None; R.A. King, None; T.L. Young, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: Terri L. Young, Divisions of Ophthalmology and Genetics Childrens Hospital of Philadelphia, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104; youngt{at}email.chop.edu.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. Y. Lam, P. O. S. Tam, D. S. P. Fan, B. J. Fan, D. Y. Wang, C. W. S. Lee, C. P. Pang, and D. S. C. Lam A Genome-wide Scan Maps a Novel High Myopia Locus to 5p15 Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 3768 - 3778. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R Rudnicka, C. G Owen, M. Richards, M. E. Wadsworth, and D. P Strachan Effect of breastfeeding and sociodemographic factors on visual outcome in childhood and adolescence Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1392 - 1399. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Pertile, M. Schache, F. M. A. Islam, C. Y. Chen, M. Dirani, P. Mitchell, and P. N. Baird Assessment of TGIF as a Candidate Gene for Myopia Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 49 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schache, A. J. Richardson, K. K. Pertile, M. Dirani, K. Scurrah, and P. N. Baird Genetic Mapping of Myopia Susceptibility Loci Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 4924 - 4929. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fotouhi, A. Etemadi, H. Hashemi, H. Zeraati, J. E Bailey-Wilson, and K. Mohammad Familial aggregation of myopia in the Tehran eye study: estimation of the sibling and parent offspring recurrence risk ratios Br. J. Ophthalmol., November 1, 2007; 91(11): 1440 - 1444. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. Chen, J. Stankovich, K. J. Scurrah, P. Garoufalis, M. Dirani, K. K. Pertile, A. J. Richardson, and P. N. Baird Linkage Replication of the MYP12 Locus in Common Myopia Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4433 - 4439. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Peet, M.-F. Cotch, R. Wojciechowski, J. E. Bailey-Wilson, and D. Stambolian Heritability and Familial Aggregation of Refractive Error in the Old Order Amish Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4002 - 4006. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Young, R. Metlapally, and A. E. Shay Complex Trait Genetics of Refractive Error Arch Ophthalmol, January 1, 2007; 125(1): 38 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dirani, M. Chamberlain, S. N. Shekar, A. F. M. Islam, P. Garoufalis, C. Y. Chen, R. H. Guymer, and P. N. Baird Heritability of Refractive Error and Ocular Biometrics: The Genes in Myopia (GEM) Twin Study Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4756 - 4761. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q Zhang, X Guo, X Xiao, X Jia, S Li, and J F Hejtmancik Novel locus for X linked recessive high myopia maps to Xq23-q25 but outside MYP1. J. Med. Genet., May 1, 2006; 43(5): e20 - e20. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-J. Qin, T. H. Margrain, C. H. To, N. Bromham, and J. A. Guggenheim Anisometropia Is Independently Associated with Both Spherical and Cylindrical Ametropia Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4024 - 4031. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Go, C. B. Hoyng, and C. C. W. Klaver Genetic Risk of Rhegmatogenous Retinal Detachment: A Familial Aggregation Study Arch Ophthalmol, September 1, 2005; 123(9): 1237 - 1241. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Paluru, S. Nallasamy, M. Devoto, E. F. Rappaport, and T. L. Young Identification of a Novel Locus on 2q for Autosomal Dominant High-Grade Myopia Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2300 - 2307. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wojciechowski, N. Congdon, H. Bowie, B. Munoz, D. Gilbert, and S. K. West Heritability of Refractive Error and Familial Aggregation of Myopia in an Elderly American Population Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1588 - 1592. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Farbrother, G. Kirov, M. J. Owen, and J. A. Guggenheim Family Aggregation of High Myopia: Estimation of the Sibling Recurrence Risk Ratio Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 2873 - 2878. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Farbrother, G. Kirov, M. J. Owen, R. Pong-Wong, C. S. Haley, and J. A. Guggenheim Linkage Analysis of the Genetic Loci for High Myopia on 18p, 12q, and 17q in 51 U.K. Families Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 2879 - 2885. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |